Resolute Holdings Management (RHLD) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Completed the acquisition of Husky Holdings, expanding into injection molding equipment and services, and entered a management agreement with Husky Holdings on terms similar to the existing CompoSecure agreement.
Net sales for Q1 2026 rose 292% year-over-year to $407.8M, driven by the Husky acquisition and organic growth at CompoSecure.
Net income attributable to common stockholders was $61.5M, reversing a loss of $3.4M in Q1 2025.
Achieved diluted EPS of $7.19, up from $(0.39) year-over-year, and Non-GAAP Fee-Related EPS of $0.69, up from $(0.07), driven by new management agreements and organic fee growth.
Repurchased $38.0M in common shares during the quarter.
Financial highlights
Net sales: $407.8M, up from $103.9M year-over-year.
Gross profit: $155.6M, up from $54.5M year-over-year.
Operating loss: $(5.8)M, down from $25.6M operating income in Q1 2025.
Diluted EPS: $7.19, up from $(0.39).
Cash and equivalents at quarter-end: $120.1M; total debt: $2,215.0M.
Outlook and guidance
Management expects continued benefits from the Husky acquisition, including revenue diversification and scale, and recurring, long-duration management fees to support future profitability.
Cautions on ongoing macroeconomic and geopolitical risks, including supply chain disruptions, inflationary pressures, and fee fluctuations.
Liquidity at both Resolute Holdings and GPGI Holdings is expected to be sufficient for at least the next 12 months.
Latest events from Resolute Holdings Management
- Q2 2026 sales jumped 296%, but margins fell; Non-GAAP Fee-Related EPS rose to $0.69.RHLD
Q2 2026 - Directors reelected and auditors ratified; final results to be filed on Form 8-K.RHLD
AGM 2026 - Election of four directors and auditor ratification are up for vote at the June 2026 meeting.RHLD
Proxy filing - Virtual meeting to elect directors and ratify auditor, with strong governance and compliance focus.RHLD
Proxy filing - 2025 saw a net loss but positive Non-GAAP Fee-Related Earnings, with improved outlook for 2026.RHLD
Q4 2025 - Flat Q1 sales and strong margin, but higher costs drove a $(3.4)M net loss to stockholders.RHLD
Q1 2025 - Virtual annual meeting to elect directors and ratify auditor, with focus on governance and oversight.RHLD
Proxy Filing - Q3 revenue rose 13% with higher margins, strong domestic growth, and a net loss per share.RHLD
Q3 2025 - Q2 2025 delivered double-digit revenue growth, margin expansion, and a net loss to common stockholders.RHLD
Q2 2025